HB
BIIB icon

Horizon Bancorp’s Biogen BIIB Stock Holding History

Horizon Bancorp’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Sell
973
-44
-4% -$8.42K 0.1% 75
2026
Q1 		$186K Buy
1,017
+35
+4% +$6.45K 0.09% 81
2025
Q4 		$173K Sell
982
-45
-4% -$7.35K 0.08% 84
2025
Q3 		$144K Buy
1,027
+391
+61% +$52.9K 0.07% 94
2025
Q2 		$80K Buy
636
+9
+1% +$1.12K 0.04% 133
2025
Q1 		$86K Buy
627
+166
+36% +$23.7K 0.05% 100
2024
Q4 		$70K Sell
461
-85
-16% -$14.3K 0.03% 107
2024
Q3 		$106K Sell
546
-32
-6% -$6.7K 0.05% 104
2024
Q2 		$134K Buy
578
+114
+25% +$24.8K 0.06% 84
2024
Q1 		$100K Buy
464
+25
+6% +$5.86K 0.05% 110
2023
Q4 		$114K Buy
439
+28
+7% +$6.88K 0.06% 92
2023
Q3 		$106K Buy
411
+322
+362% +$86.1K 0.07% 83
2023
Q2 		$25K Buy
89
+50
+128% +$14.9K 0.02% 147
2023
Q1 		$11K Buy
+39
New +$10.8K 0.01% 133
2020
Q3 		$28K Buy
+100
New +$27.9K 0.04% 171

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Horizon Bancorp's BIIB Position: Q2 2026 in Review

Horizon Bancorp reduced its Biogen (BIIB) stake by 4.3% in Q2 2026, selling an estimated $8.42K and leaving 973 shares worth $210K. The position accounts for 0.1% of the portfolio, ranked #75.

Horizon Bancorp first reported a position in BIIB in Q3 2020 and has held it in 15 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Horizon Bancorp held 973 shares of Biogen worth $210K as of Q2 2026.
  • Horizon Bancorp sold 44 Biogen shares in Q2 2026, an estimated $8.42K.
  • Biogen made up 0.1% of Horizon Bancorp's portfolio in Q2 2026, its #75 holding.
  • Horizon Bancorp first reported a position in Biogen in Q3 2020 and has held it in 15 quarters since.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Horizon Bancorp's 13F filing for Q2 2026, filed 4 Aug 2026.